Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Giugliani

Showing results (41-50 of 482) with videos related to

Pageof 49
Sort By:
Jornal De Pediatria|September 10, 2014
Microarray-based comparative genomic hybridization analysis in neonates with congenital anomalies: detection of chromosomal imbalancesLuiza Emy Dorfman, Júlio César L Leite, Roberto Giugliani, et al.
Pediatric Endocrinology Reviews : PER|October 28, 2014
Therapy for mucopolysaccharidosis VI: (Maroteaux-Lamy syndrome) present status and prospectsRoberto Giugliani, Silvani Herber, Louise Lapagesse, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|October 23, 2009
The March of Dimes Global Network for Maternal and Infant Health: Harnessing the power of experts in lower-income countries to improve the health of women, mothers, newborns and babiesChristopher P Howson, Nanbert Zhong, Carmencita Padilla, et al.
Archives of Disease in Childhood|November 3, 2020
Improvement in time to treatment, but not time to diagnosis, in patients with mucopolysaccharidosis type IRoberto Giugliani, Nicole Muschol, Hillary A Keenan, et al.
Molecular Genetics and Metabolism Reports|August 2, 2019
The migalastat GLP-HEK assay is the gold standard for determining amenability in patients with Fabry diseaseRaphael Schiffmann, Daniel G Bichet, Elfrida Benjamin, et al.
Journal of Microencapsulation|February 20, 2013
Treatment of MPS I mice with microencapsulated cells overexpressing IDUA: effect of the prednisolone administrationValeska Lizzi Lagranha, Talita Giacomet de Carvalho, Roberto Giugliani, et al.
Journal of Inherited Metabolic Disease|November 10, 2012
Important aspects in the molecular diagnosis of mucopolysaccharidosesAna Carolina Brusius-Facchin, Francyne Kubaski, Roberto Giugliani, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|June 9, 2017
Hydrocephalus and mucopolysaccharidoses: what do we know and what do we not know?Amauri Dalla Corte, Carolina F M de Souza, Maurício Anés, et al.
Molecular Genetics and Metabolism Reports|May 31, 2018
Risks of long-term port use in enzyme replacement therapy for lysosomal storage disordersChristian J Hendriksz, Paul Harmatz, Roberto Giugliani, et al.
Current Pharmaceutical Biotechnology|April 22, 2011
Recent Advances in Treatment Approaches of Mucopolysaccharidosis VIRoberto Giugliani, Clarissa Gutiérrez Carvalho, Silvani Herber, et al.
Pageof 49

Showing results (41-50 of 482) with videos related to

Sort By:
Pageof 49
Jornal De Pediatria|September 10, 2014
Microarray-based comparative genomic hybridization analysis in neonates with congenital anomalies: detection of chromosomal imbalancesLuiza Emy Dorfman, Júlio César L Leite, Roberto Giugliani, et al.
Pediatric Endocrinology Reviews : PER|October 28, 2014
Therapy for mucopolysaccharidosis VI: (Maroteaux-Lamy syndrome) present status and prospectsRoberto Giugliani, Silvani Herber, Louise Lapagesse, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|October 23, 2009
The March of Dimes Global Network for Maternal and Infant Health: Harnessing the power of experts in lower-income countries to improve the health of women, mothers, newborns and babiesChristopher P Howson, Nanbert Zhong, Carmencita Padilla, et al.
Archives of Disease in Childhood|November 3, 2020
Improvement in time to treatment, but not time to diagnosis, in patients with mucopolysaccharidosis type IRoberto Giugliani, Nicole Muschol, Hillary A Keenan, et al.
Molecular Genetics and Metabolism Reports|August 2, 2019
The migalastat GLP-HEK assay is the gold standard for determining amenability in patients with Fabry diseaseRaphael Schiffmann, Daniel G Bichet, Elfrida Benjamin, et al.
Journal of Microencapsulation|February 20, 2013
Treatment of MPS I mice with microencapsulated cells overexpressing IDUA: effect of the prednisolone administrationValeska Lizzi Lagranha, Talita Giacomet de Carvalho, Roberto Giugliani, et al.
Journal of Inherited Metabolic Disease|November 10, 2012
Important aspects in the molecular diagnosis of mucopolysaccharidosesAna Carolina Brusius-Facchin, Francyne Kubaski, Roberto Giugliani, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|June 9, 2017
Hydrocephalus and mucopolysaccharidoses: what do we know and what do we not know?Amauri Dalla Corte, Carolina F M de Souza, Maurício Anés, et al.
Molecular Genetics and Metabolism Reports|May 31, 2018
Risks of long-term port use in enzyme replacement therapy for lysosomal storage disordersChristian J Hendriksz, Paul Harmatz, Roberto Giugliani, et al.
Current Pharmaceutical Biotechnology|April 22, 2011
Recent Advances in Treatment Approaches of Mucopolysaccharidosis VIRoberto Giugliani, Clarissa Gutiérrez Carvalho, Silvani Herber, et al.
Pageof 49